• Viking Therapeutics Stock: Can VK2735 Beat Wegovy & Zepbound?

    Source: Buzz FX / 18 Mar 2025 09:01:16   America/New_York


    Is Viking Therapeutics the Next Blockbuster GLP-1 Stock? Written by Jea Yu | Reviewed by Shannon Tokheim March 18, 2025 Share Link copied to clipboard. Key Points Viking’s VK2735 GLP-1 drug has shown 13.1% placebo-adjusted weight loss in ju
    Read more...
Share on,